Found 0 matching trials
A Pilot Study of the Thrombopoietin-Receptor Agonist Eltrombopag in Refractory Aplastic Anemia Patients PHASE2 Severe aplastic anemia (SAA) is a life-threatening blood disease which can ...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP) PHASE3 This is a Phase II/III multicenter study comprising of the double-blind, fo...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Rollover Study to Provide Continued Treatment With Eltrombopag PHASE4 The objective of this study was to provide continued treatment with eltromb...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
TPO-RAs Combining Anti-CD 20 Monoclonal Antibody Versus TPO-RAs in the Management of Pediatric Primary Immune Thrombocytopenia (ITP) PHASE4 This multicenter randomized, open-label study aim to compare the efficacy a...
Show More Location
Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
A Study to Assess the Safety and Efficacy of Eltrombopag in Japanese Subjects With Refractory, Moderate or More Severe Aplastic Anemia PHASE2 This was a non-randomized, open-label, phase II study to assess the efficac...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Eltrombopag for Treatment of Fanconi Anemia PHASE2 An open-label, phase II study to assess the efficacy and safety of eltrombo...
Show More Location
Hospital Infantil Universitario Niño Jesús (HIUNJ)
Learn More & Join Trial
ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP N/A The purpose of this study is to understand physician treatment decisions in...
Show More Location
Arkansas Children's Hospital
Learn More & Join Trial
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP) PHASE2 The purpose of this study is to investigate the tolerability of ianalumab (...
Show More Location
Highlands Oncology Group
Learn More & Join Trial
The Use of Eltrombopag Post HSCT in BMFD PHASE2 Bone marrow failure disease(BMFD) is a kind of bone marrow due to congenita...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
Safety and Efficacy of Eltrombopag at Escalated Doses PHASE2 Study rationale is based on the data that in previous clinical studies of e...
Show More Location
Weill Cornell Medicine
Learn More & Join Trial